Jan 25 |
Pharma Stock Roundup: JNJ Reports Q4 Earnings, SNY Inks M&A Deal With INBX
|
Jan 24 |
Biotech Stock Roundup: GILD Down on Study Results, INBX Gains on Sanofi Deal & More
|
Jan 24 |
Sanofi Expands Rare Disease Focus With Inhibrx's INBRX-101 Acquisition
|
Jan 24 |
Inhibrx, Inc. (INBX) Soars 8.9%: Is Further Upside Left in the Stock?
|
Jan 23 |
Inhibrx (INBX) Up 6% on Sale of Rare Disease Drug to Sanofi
|
Jan 23 |
Sanofi Barrels Into Liver Disease Space With $1.7 Billion Takeover Of Inhibrx
|
Jan 23 |
Health Care Roundup: Market Talk
|
Jan 23 |
These Stocks Are Moving the Most Today: Logitech, 3M, United Airlines, D.R. Horton, GE, and More
|
Jan 23 |
Sanofi to buy Inhibrx in deal worth up to $2.2B
|
Jan 23 |
Sanofi to Buy Assets From Inhibrx in Deal Valued at Up to $2.2 Billion
|